Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “labelling”
Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
ClinicalTrials.gov study NCT00567918. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Study: Treatment of ALS Fatigue With PolyMVA
ClinicalTrials.gov study NCT04557410. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on Cognition
ClinicalTrials.gov study NCT07168824. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Open Label Phase II Study of BAY 43-9006 in Chronic Myelogenous Leukemia (CML) Patients Resistant to Gleevec
ClinicalTrials.gov study NCT00661180. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial
ClinicalTrials.gov study NCT06716073. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old
ClinicalTrials.gov study NCT01932541. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler Device
ClinicalTrials.gov study NCT04631354. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
ClinicalTrials.gov study NCT00001757. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an Anti-PD-L1 ADC) in Subjects With Advanced Colorectal Cancer
ClinicalTrials.gov study NCT07106892. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open Label, Multi-center, Phase I Clinical Study to Evaluate the Safety, Effectiveness and Pharmacokinetic Characteristics of SIM1803-1A in Patients With Locally Advanced/Metastatic Solid Tumors Wi
ClinicalTrials.gov study NCT04671849. IPD Sharing: NO. Countries: 1. Publications: 0.
Effects of Sugary Drink Warning Labels on Parent Choices
ClinicalTrials.gov study NCT04259385. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open Label 100 Person Study Evaluating a Natural Supplement for Weight Loss and Fat Loss.
ClinicalTrials.gov study NCT07152470. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Open Label Placebo to Reduce Prescription Opioid Use
ClinicalTrials.gov study NCT05014230. IPD Sharing: NO. Countries: 1. Publications: 0.
Open Label Study of BAY1082439 in Patients With Advanced Cancer
ClinicalTrials.gov study NCT01728311. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial
ClinicalTrials.gov study NCT05040464. IPD Sharing: NO. Countries: 1. Publications: 0.
Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-1
ClinicalTrials.gov study NCT04456049. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
ClinicalTrials.gov study NCT01818076. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphom
ClinicalTrials.gov study NCT06047080. IPD Sharing: YES. Countries: 21. Publications: 0.
Message Framing and Policy Support for Front-of-package Labeling
ClinicalTrials.gov study NCT06296342. IPD Sharing: YES. Countries: 1. Publications: 0.
A Fixed-Sequence, Two-Period, Open-Label Drug-Drug Interaction Study to Assess the Effect of an Inhibitor of Cytochrome P450 Isoenzyme 3A4 and Permeability Glycoprotein 1 on the Pharmacokinetics of TD
ClinicalTrials.gov study NCT01568411. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.